Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Hematology Hematology for November/December 2019 BCL11A-directed gene therapy advances in sickle cell disease, Oral arginine emerges as potential adjuvant for vaso-occlusive crisis management, NFIX could be a target for sickle cell therapy, Fragmentation of sickle cell disease care starts in young adulthood, Global Blood Supply Runs Low, More must reads Hematology for September/October 2019 New Consensus Recommendations on Bleeding in Acquired Hemophilia, Rivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APS, More must readsHematology for July/August 2019 Osteoporotic Fracture Risk Appears Higher in Adults with Hemophilia, RNA Interference Drug Fitusiran Effective in both Hemophilia A and B, Gene Therapy for Hemophilia A Associated With Sustained Reductions in Bleeding Rates, Minor Surgeries Safe for Hemophilia Patients on Emicizumab, BRCA2 mutations linked to childhood NHL, More must readsHematology for May/June 2019 Study: Why urban sickle cell patients quit hydroxyurea, Femoral head decompression relieves SCD hip pain, Oral voxelotor improves hemoglobin in sickle cell disease, Gabapentin falls short in treating sickle cell pain, Extended Half-Life Clotting Factors Cut Infusions, Hike Prices, More must readsHematology for March/April 2019 Study highlights lack of data on transgender leukemia patients, AUGUSTUS: Dual surpasses triple therapy when AFib patients have PCI or ACS, Andexanet alfa effectively reverses factor Xa inhibition, Repeat VTE risk heightened in HIV patients, Novel transplant regimen improves survival in primary immunodeficiency, More must readsPages« first 1 2 3 4 last »
